The cause of early oncogenesis in hepatitis B virus (HBV)-related childhood hepatocellular carcinoma (HCC) remains unclear. This study investigated whether pre-S deletion of HBV is related to childhood HCC. By using nested polymerase chain reaction, we compared the pre-S sequence of HBV from sera of children with HCC against control children with similar chronic HBV infection. The HBV in sera of children with HCC had a significantly higher rate of pre-S deletion than that of children with chronic HBV infection (p ϭ 0.008). All except one of the pre-S deletions from the HCC group involved the pre-S2 region, whereas no pre-S2 deletion was found in the chronic HBV group (p ϭ 0.003). There was a trend whereby genotype-C sera had a higher rate of pre-S2 deletion than genotype-B sera (p ϭ 0.11). A multivariate logistic regression model revealed that pre-S deletion was an independent risk factor for HCC in children (odds ratio: 36.69, p ϭ 0.015). In conclusion, pre-S2 deletion does not need to take decades to occur; its presence in nearly half of children with HCC, in contrast to its absence in children with chronic HBV infection, suggests a link between pre-S2 deletion and HCC development in children. (Pediatr Res 67: 90-94, 2010)
C hronic hepatitis B virus (HBV) infection, which poten-
tially causes severe complications, such as liver cirrhosis and hepatocellular carcinoma (HCC) (1) , is a grave threat to human health in hyperendemic regions. Patients with chronic HBV infection undergo variable clinical courses and have different outcomes. One such outcome is the development of HCC in children after a relatively short period of HBV infection; they are mostly HBV e antigen (HBeAg) negative and anti-HBe positive at the diagnosis of HCC (2) . However, the key risk factors responsible for HCC development, particularly the early onset of HCC in children, remain largely unclear.
In children with chronic HBV infection, some specific HBV genotypes and mutations in the HBV genome have been shown to have significant impact on the clinical course or outcome (3) (4) (5) . Genotype B predominates in children with both chronic HBV infection and HCC in Taiwan, whereas genotype C delays HBeAg seroconversion (4) . In addition, children with earlier emergence of the precore stop codon mutant (G1896A) tend to have more severe hepatocellular damage (3) and account for about half of childhood HBeAg seroconversion (5) . In the core promoter region, higher rates of A1775G and G1799C mutations and a lower rate of the A1752G mutation have been found in childhood HBeAg seroconverters (5) . In the core gene region, children with HCC have more mutations than those with chronic HBV infection (6) ; in addition, the HCC group has mutation hotspots at core gene codons 74, 87, and 159, whereas the chronic HBV group has mutation hotspots at core gene codons 21, 65 , and 147 (6) .
In an attempt to identify a broader spectrum of important features of HBV genomes linked to childhood HCC, we had previously sequenced the whole genome of HBV isolated from the serum of three children with HCC and found that one of them contained a pre-S deletion in the HBV genome. Therefore, in this study, we compared the pre-S region between children with HBV-related HCC and with chronic HBV infection to investigate if pre-S deletion is associated with HCC development in children. In addition, because adult HBV carriers with either basal core promoter mutation (A1762T and G1764A) or precore mutation (G1896A) have been shown to have a higher risk for HCC (7, 8) , we also determined the prevalence of both mutations in our patients and included these data with that of pre-S deletion in a multivariate analysis.
PATIENTS AND METHODS
Children with HCC. Nineteen children (male:female ϭ 13:6) with HBVrelated HCC who were diagnosed before the age of 15 were included in this study. The majority of cases (15/19) had pathologic samples, and the diagnosis of HCC was made by pathologists in our hospital. For the other four patients who refused liver biopsy due to the advanced stage of the disease, the older age of onset, a positive maternal HBV surface antigen (HBsAg), elevated alpha-fetoprotein levels, and imaging studies, including sonography, computed tomography, and magnetic resonance imaging, confirmed the diagnosis according to the guideline of the American Association for the Study of Liver Diseases (9) . After the diagnosis of HCC, the follow-up period ranged from 1 mo to 24.5 y. Blood samples were drawn immediately after the establishment of diagnosis (average age: 12.7 Ϯ 6.6 y).
Control group: children with chronic HBV infection. We longitudinally followed up 415 HBsAg carrier children who were less than 15-y old at enrollment. Among them, we randomly selected 19 age-and gender-matched children (Table 1) to compare the serum HBV pre-S sequence with the same sequence in 19 cases of HCC. There was no difference between the control group and the HCC group in terms of the rate of HBeAg seroconversion (HBeAg seronegative and anti-HBe seropositive) and the distribution of HBV genotypes. We did not know the status of their basal core promoter and precore mutations before the study.
Determination of HBV genotypes and viral loads. Serum HBV genotypes were determined by polymerase chain reaction (PCR) with genotype-specific primers as described previously (10) . The viral load (HBV DNA quantification, copies/mL) was determined by real-time PCR as described previously (10) . The sensitivity of this method was 10 3 copies/mL. Extraction of DNA from sera. Serum DNA was extracted from 200 L serum by QIAamp DNA mini kit (Qiagen), following the instructions of the manufacturer. The DNA was dissolved in 100 L double-distilled water.
Nested PCR to amplify the pre-S region and direct sequencing. To amplify the pre-S region of HBV, we performed nested PCR with two pairs of HBV genotype B and genotype C-co-positive primers (PS1/PS2 for the first round, PS3/PS4 for the second round) (11) . The primers were as follows: PS1 (nt 2814 -2839): 5Ј-GGGTCACCTTATTCTTGGGA-3Ј, PS2 (nt 208 -189): 5Ј-CCCCGCCTGTAACACGAGCA-3Ј, PS3 (nt 2828 -2847): 5Ј-TTGG-GAACAAGATCTACAGC-3Ј, and PS4 (nt 176 -157): 5Ј-GTCCTGATGC-GATGTTCTCC-3Ј. The polymerase for PCR was Prime TaqDNA polymerase (Genet Bio., Korea), and the final volume of PCR reactions was 50 L. The condition used for PCR was 94°C for 2 min, followed by 36 cycles of 94°C for 1 min, 58°C for 30 s, and 72°C for 1 min. To amplify the precore/core region of HBV, we performed nested PCR with two pairs of HBV genotype B and genotype C-co-positive primers (PS1/PS2 for the first round, PS3/PS4 for the second round) (11) . The primers were as follows: PC1 (nt 1652-1671): 5Ј-ACATAAGAGGACTCTTGGAC-3Ј, PC2 (nt 1977-1957): 5Ј-GAAGGAAAGAAGTCAGAAGGC-3Ј, PC3 (nt 1704 -1725): 5Ј-TACTTCAAAGACTGTGTGTTTA-3Ј, and PC4 (1966 -1947): 5Ј-GTCA-GAAGGCAAAAAAGAGA-3Ј. The condition used for PCR was 94°C for 2 min, followed by 36 cycles of 94°C for 1 min, 45°C for 30 s, and 72°C for 1 min. The amplified PCR products were separated by electrophoresis, and all visible bands were cut and purified from the 1.5% agarose gel with a Gel/PCR DNA Fragments Extraction Kit (Geneaid Biotech, Taiwan). The PCR products were then sequenced directly. HBV nucleotides were numbered from the EcoRI site. To avoid contamination in PCR, we used distilled water to replace cDNA as the negative control in each PCR reaction and followed the precautions described elsewhere (12) to avoid false positives.
Cloning of PCR products and isolation of plasmid DNA. For two PCR products of the pre-S region containing multiple sequences shown by direct sequencing, the purified PCR products were cloned using the TOPO XL Cloning Kit (Invitrogen/Life Technologies), and the plasmid DNA was extracted with Mini-M Plasmid DNA Extraction System (Viogene Biotek, Taiwan). At least five DNA samples were then sequenced. The representative sequences were selected from the clones that were completely identical to at least one other clone.
Sequence alignment. Sequences were translated and aligned using ClustalW (13) , back translated to their corresponding DNA sequences by the TRANSALIGN software of the EMBOSS package (14) , and edited manually. The nucleotide and amino acid sequences of the nine HCC-related HBV pre-S region reported in this study are available in the GenBank database under the accession numbers FJ210940, FJ224090-94, and FJ231724-26.
Ethical considerations. All blood samples of the patients in this study were drawn following written informed consent from parents of the patients or the patients themselves. The Ethical Committee of the National Taiwan University Hospital approved the protocol of this study. All sera in this study were processed so as to protect personal information.
Statistical analysis. Fisher's exact test, t test, or 2 test with Yates' correction were used to test for statistical significance, whenever the most appropriate. The odds ratio and 95% CI were estimated by unconditional logistic regression model to evaluate the association of different risk factors with childhood HCC. The Kaplan-Meier method was used to calculate cumulative survival rates, whereas the difference between groups was analyzed using log-rank tests. The statistical analysis was performed using STATA software (version 8.2; Stata Corp, College Station, TX). p values less than 0.05 were considered significant.
RESULTS
Pre-S deletion is an independent risk factor for children with HCC. By using nested PCR, we successfully amplified and isolated HBV pre-S DNA sequences from the sera of 19 children with HCC and 19 children with chronic HBV infection. The clinical characteristics and the rates of pre-S deletion in PCR-amplifiable patients are shown in Table 1 . The age, gender, HBsAg (ϩ) rate, HBV viral load, and genotype distribution of both groups are well matched (Table 1) . In contrast, HBV DNA sequence analysis indicated a much higher rate of pre-S deletion occurring in the sera from children with HCC (47.4%, 9 of 19) than from children with chronic HBV infection (5.3%, 1 of 19; p ϭ 0.008). In addition, in the HCC group, there was a trend whereby genotype-C sera had a higher rate of pre-S2 deletion than genotype-B sera (4 of 5 vs 4 of 14, p ϭ 0.11). We also compared the rate of basal core promoter mutation (A1762T and G1764A) and precore mutation (G1896A) in our patients (Tables 1 and 2 ) and found no significant difference between HCC and chronic HBV infection groups. A multivariate logistic regression model (Table 2 ) revealed that only pre-S deletion was an independent risk factor for HCC in children (odds ratio: 36.69, 95% CI: 2.04 -669.62; p ϭ 0.015). In addition, we compared the clinical presentation and outcome of pre-S deleted and nondeleted HCC children and found that the tumor size (6.0 Ϯ 3.8 cm vs 6.6 Ϯ 2.8 cm, p ϭ 0.7), the rate of multiple tumors (44 vs 50%, p ϭ 1), and the survival time (Supplementary material, Table S1 , http://links.lww.com/A55; p ϭ 0.14, log-rank test, by Kaplan-Meier survival analysis) were not statistically different between two groups. Pre-S2, rather than pre-S1 deletions, occurred exclusively in nearly half of the children with HCC. Further analysis of pre-S deletions (Table 3) indicated that 88.9% (eight of nine) of the pre-S deletions in the HCC group involved the pre-S2 region (Fig. 1, Supplementary material, Fig. S1 , and Table 3 , http://links.lww.com/A55). The deletion sizes ranged from 15 base pairs (bp) to 207 bp (Table 3 ). In contrast, the only case of pre-S deletion in the chronic HBV infection group (Table 3 , patient 5957) was in the pre-S1 region. Therefore, the HBV in the HCC group had a significantly higher rate of pre-S2 deletion than in the age-matched chronic HBV group (Table 1 Functional sites potentially involved in HCC-related pre-S deletions-focusing on the N-terminal half of pre-S2. To understand the possible impact of pre-S deletions on the function of HBV, we analyzed the patterns of all HCC-related pre-S deletions (Fig. 1) . Remarkably, we found that most (89%, 8 of 9) of the pre-S deletions and all the pre-S2 deletions (8 of 8) involved a specific region-the N-terminal half of pre-S2 ( Fig. 1 and Supplementary material, Fig. S1 , http://links.lww.com/A55), followed by the C-terminal half of the pre-S1 region (44%, four of nine). Therefore, the region extending from the C-terminal half of pre-S1 to the N-terminal half of pre-S2 seemed to be the preferred target region of deletion, and indeed, in two cases (patients 7 and 9; Fig. 1 ), the pre-S deletions included both the C-terminal half of pre-S1 and the N-terminal half of pre-S2. Several well-known B-and T-cell epitopes (Fig. 1) overlap with this region. Among them, the B-cell epitope at amino acids 120 to 145 was most frequently deleted (89%, eight of nine; Fig. 1 ), followed by the T-cell epitope at amino acids 140 to 149 (44%, four of nine; Fig. 1 ). In addition, we also determined which of the wellknown functional domains of HBV were potentially affected by these deletions ( Table 4 ). The domains most frequently involved were the transactivator domain in pre-S2 (89%) and the polymerized human serum albumin (PHSA)-binding site (89%), followed by the nucleocapsid binding site (78%) and the domain responsible for viral secretion (56%).
DISCUSSION
HBV-related HCC is very rare in children, but such clinical samples (e.g., blood) are highly valuable for testing different hypotheses of the oncogenic mechanism of HBV, as cancers in children are less affected by environmental factors than the equivalent cancers in adults. Our study showed a significantly higher rate of pre-S2 deletions in the children of the HCC group than in the group with chronic HBV infection. The meaning of our results is unique and not merely in agreement with the studies in adults, because we found that pre-S2 deletions in HBV genomes did not necessarily take decades to accumulate, as in adult patients with advanced liver diseases (1, (15) (16) (17) (18) (19) (20) (21) (22) ; they emerged in nearly half of the young children with HBV-related HCC that developed in a relatively short period of time.
Our results show that pre-S deletions in children are more often in the C-terminal half of the pre-S1 region and the N-terminal half of the pre-S2 region, a continuous region that overlaps several B-or T-cell epitopes (23, 24) . Such deletions, which were similar to those found in adults (20 -22) , may offer HBV mutants an advantage in escaping immune attack. This region also overlaps nine HBV domains with important functions (25) (26) (27) (28) (29) (30) (31) . Four of them, including domains for PHSA binding, pre-S2 transactivator, nucleocapsid binding, and viral secretion, were more frequently involved in our pre-S deletion clones (Table 4) . It has been suggested that functional impairment of nucleocapsid binding (28, 29) and PHSA binding (31) caused by pre-S deletions may cause viral immaturities and create mutant viruses containing altered envelope proteins, respectively. Such immature or mutant viral particles tend to be retained intracellularly (16) and cause endoplasmic reticulum-stress (32, 33 ) that leads to oxidative stress and DNA damage (32) , which may contribute to HCC formation. Nevertheless, we observed no significant difference between the HCC patients and non-HCC patients in terms of viral load (Table 1) . One possible explanation is that almost all these patients were early HBeAg seroconverters. Hence, the viral loads of the majority (13 of 19 patients in HCC group and 14 of 19 patients in chronic HBV group) were so low (less than 10 3 copies/mL, calculated as 10 3 ) that the real-time PCR method we used (with a sensitivity around 10 3 copies/mL) did not allow us to obtain exact values and distinguish the differences.
We reason that an interplay of genetic, immunologic, and viral factors may be responsible for early emergence of the HBV with pre-S2 deletions in children with HCC. For example, most of these children were likely to have acquired HBV infection perinatally, because most of their mothers were HBV carriers (3). Early HBeAg seroconversion is the other wellknown feature of these HCC children (2). Our results also indicated that in the HCC group, there was a trend toward a higher rate of pre-S2 deletion in genotype-C sera than in genotype-B sera (80 vs 29%, p ϭ 0.11), a phenomenon also observed in adults (34) , but such a trend was not seen in our control group, because none of them had pre-S2 deletion. Lack of pre-S2 deletion in our chronic HBV infection group, which differs from what Lin et al. (34) , Fang et al. (20) , and Chen et al. (21) have reported in adults (12.4, 12.1, and 15.0%, respectively), may be explained by the fact that the age of our control group (range, 11.3-14.2 y) was much younger than theirs (range, 17-79 y, 30 -55 y, and 38.3-59.5 y, respectively). The duration of infection seemed to contribute to the accumulation of pre-S2 deletions in non-HCC adult patients with chronic HBV infection. However, early emergence of pre-S2 deletions is a unique feature in childhood HCC and suggests an important role in the early hepatocarcinogenesis in children. Alternatively, it is possible that the early onset of HCC was caused by host genetic predispositions to HCC, and the selection of the deletion mutants could represent the shutoff of HBV replication by cancerous tissues because they were less supportive of viral life cycle than untransformed hepatocytes. However, this possibility is less favored, because our observations (data not shown) and previous studies (16, 32, 33) have shown that in the HCC livers, the characteristic immunostaining pattern of the large surface antigen with pre-S2 deletions is only found in the nontumor hepatocytes but not in the tumor cells.
In conclusion, our study of children with HBV-related HCC provides strong evidence that pre-S2 deletion is linked to HCC HSC70  CAD  NBS  TD-1  TD-2  S-P  CBF  VS  PHSA   1  P  -P  P  P  P  -P  C  2  --P  -P  --C  P  3  --P  -P  ---P  4  --P  -P  --P  P  5  ----P  ---P  6  P  --P  -P  ---7  P  P  C  -P  P  C  C  P  8 --P -P ---P 9 P P C P P P P C C Involved (%)*  44  22  78  33  89  44  22 development. Thus, patients with pre-S2 deletions may benefit greatly from a more intensive follow-up strategy for early detection of HCC.
